Clinical Trial: Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07655128) titled 'Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life' on June 09.

Brief Summary: The goal of this clinical trial is to learn if subcutaneous ePGT121v1-LS added to standard antiretroviral therapy (ART) is safe and helps improve HIV viral suppression in infants living with HIV in South Africa. The study will also learn how the body processes ePGT121v1-LS and whether caregivers and health workers find this treatment approach acceptable.

The main questions it aims to answer are:

* Is ePGT121v1-LS safe and well tolerated in infants living with HIV?

* Does adding ePGT121v1-LS to standard ART increase the numbe...